Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
Perspective TherapeuticsJohnson & Johnson
Last price
$2.57$252.93
Currency
USD
USD
$293M$610B
-29.32
-$1.25$8.63
1.800.23
0$5.28
02.12%
Sector
HealthHealth
Employees
165138,200
Ticker
$CATX$JNJ
Primary listing
AMEXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in $CATX or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.